Thiocoraline alters neuroendocrine phenotype and activates the N otch pathway in MTC‐TT cell line
S Tesfazghi, J Eide, A Dammalapati… - Cancer …, 2013 - Wiley Online Library
Medullary thyroid cancer (MTC) is an aggressive neuroendocrine tumor (NET). Previous
research has shown that activation of N otch signaling has a tumor suppressor role in NET s …
research has shown that activation of N otch signaling has a tumor suppressor role in NET s …
Genetics of pancreatic neoplasms and role of screening
VS Katabathina, OY Rikhtehgar… - Magnetic …, 2018 - mri.theclinics.com
The broad spectrum of pancreatic neoplasms may be classified based on the direction of
cellular differentiation into exocrine and endocrine tumors. Pancreatic ductal …
cellular differentiation into exocrine and endocrine tumors. Pancreatic ductal …
[HTML][HTML] Tuberous Sclerosis Complex with rare associated findings in the gastrointestinal system: a case report and review of the literature
LB Reis, D Konzen, CBO Netto, PMB Braghini… - BMC …, 2020 - Springer
Abstract Background Tuberous Sclerosis Complex (TSC) is a complex and heterogeneous
genetic disease that has well-established clinical diagnostic criteria. These criteria do not …
genetic disease that has well-established clinical diagnostic criteria. These criteria do not …
Cytopathology and clinicopathological correlation of renal neuroendocrine neoplasms
X Lin, T Antic, T Hou, BG Nezami - Journal of the American Society of …, 2024 - Elsevier
Background There is a lack of documentation regarding cytopathology of renal
neuroendocrine neoplasms (NENs) due to their rarity. Design Five cytology cases were …
neuroendocrine neoplasms (NENs) due to their rarity. Design Five cytology cases were …
Pancreatic neuroendocrine tumors: current opinions on a rare, but potentially curable neoplasm
Pancreatic neuroendocrine tumors (PNETs) share a unique genetic identity, functional
behavior, and clinical course. Compared with tumors of the exocrine pancreas, they are rare …
behavior, and clinical course. Compared with tumors of the exocrine pancreas, they are rare …
Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers
M Andrea, T Weinschenk, O Schoor, J Fritsche… - US Patent …, 2020 - Google Patents
2018-07-20 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Синдром Золлингера–Эллисона: современные аспекты диагностики и лечения
ИВ Маев, ДН Андреев, ЮА Кучерявый… - Российский журнал …, 2024 - gastro-j.ru
Заключение. Несмотря на то, что СЗЭ не относится к широко распространенным
заболеваниям, знание о клиническом течении этой патологии важно для ее …
заболеваниям, знание о клиническом течении этой патологии важно для ее …
[HTML][HTML] Cancer chemosensitivity testing
Y Su - Journal of Cancer Therapy, 2014 - scirp.org
Since chemotherapy started in 1940s, chemosensitivity testing has been both a very
attractive field and one fraught with potential pitfalls. Many methods were developed and …
attractive field and one fraught with potential pitfalls. Many methods were developed and …
[HTML][HTML] Эволюция клинических представлений о синдроме Золлингера-Эллисона
ИВ Маев, ДН Андреев, ЮА Кучерявый… - Терапевтический …, 2014 - cyberleninka.ru
Представлены современные взгляды на диагностику и лечение синдрома Золлингера-
Эллисона (СЗЭ). Подчеркивается важность включения СЗЭ в круг дифференциальной …
Эллисона (СЗЭ). Подчеркивается важность включения СЗЭ в круг дифференциальной …
Genetics and epigenetics of pancreatic neuroendocrine tumors and pulmonary carcinoids
In this chapter, we give an overview of the genetic and epigenetic background of
neuroendocrine tumors (NETs), in particular pancreatic and pulmonary NETs. Studying the …
neuroendocrine tumors (NETs), in particular pancreatic and pulmonary NETs. Studying the …